Td Asset Management Inc Dyne Therapeutics, Inc. Transaction History
Td Asset Management Inc
- $102 Billion
- Q1 2025
A detailed history of Td Asset Management Inc transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 21,656 shares of DYN stock, worth $276,547. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,656
Previous 72,030
69.93%
Holding current value
$276,547
Previous $1.7 Million
86.68%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding DYN
# of Institutions
216Shares Held
116MCall Options Held
322KPut Options Held
66.2K-
Janus Henderson Group PLC London, X010.4MShares$132 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA9.71MShares$124 Million2.11% of portfolio
-
Atlas Venture Life Science Advisors, LLC9.13MShares$117 Million27.97% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.41MShares$94.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$94.3 Million0.01% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $661M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...